131 related articles for article (PubMed ID: 19944150)
1. Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine production.
Liu J; Mani S; Schwartz R; Richman L; Tabor DE
Vaccine; 2010 Feb; 28(5):1285-93. PubMed ID: 19944150
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tumorigenic potential of high yielding cloned MDCK cells for live-attenuated influenza vaccine using in vitro growth characteristics, metastatic gene expression and in vivo nude mice model.
Vepachedu RS; Menon A; Hussain AI; Liu J
Biologicals; 2012 Nov; 40(6):482-94. PubMed ID: 22902973
[TBL] [Abstract][Full Text] [Related]
3. Safety assessment of Madin Darby canine kidney cells as vaccine substrate.
Medema JK; Meijer J; Kersten AJ; Horton R
Dev Biol (Basel); 2006; 123():243-50; discussion 265-6. PubMed ID: 16566450
[TBL] [Abstract][Full Text] [Related]
4. Characterization of chemically and virally transformed variants of Madin-Darby canine kidney (MDCK) epithelial cells.
U HS; Boerner P; Rindler MJ; Chuman L; Saier MH
J Cell Physiol; 1985 Feb; 122(2):299-307. PubMed ID: 2981894
[TBL] [Abstract][Full Text] [Related]
5. Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.
Brands R; Visser J; Medema J; Palache AM; van Scharrenburg GJ
Dev Biol Stand; 1999; 98():93-100; discussion 111. PubMed ID: 10494962
[TBL] [Abstract][Full Text] [Related]
6. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenicity assessments of Per.C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line.
Ledwith BJ; Lanning CL; Gumprecht LA; Anderson CA; Coleman JB; Gatto NT; Balasubramanian G; Farris GM; Kemp RK; Harper LB; Barnum AB; Pacchione SJ; Mauer KL; Troilo PF; Brown ER; Wolf JJ; Lebronl JA; Lewis JA; Nichols WW
Dev Biol (Basel); 2006; 123():251-63; discussion 265-6. PubMed ID: 16566451
[TBL] [Abstract][Full Text] [Related]
8. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).
Doroshenko A; Halperin SA
Expert Rev Vaccines; 2009 Jun; 8(6):679-88. PubMed ID: 19485748
[TBL] [Abstract][Full Text] [Related]
9. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
[TBL] [Abstract][Full Text] [Related]
11. Transformation of epithelial Madin-Darby canine kidney cells with p60(v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness.
Kadono Y; Okada Y; Namiki M; Seiki M; Sato H
Cancer Res; 1998 May; 58(10):2240-4. PubMed ID: 9605772
[TBL] [Abstract][Full Text] [Related]
12. Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.
Tatalick LM; Gerard CJ; Takeya R; Price DN; Thorne BA; Wyatt LM; Anklesaria P
Vaccine; 2005 Apr; 23(20):2628-38. PubMed ID: 15780446
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform.
Ganguly M; Yeolekar L; Tyagi P; Sagar U; Narale S; Anaspure Y; Tupe S; Wadkar K; Ingle N; Dhere R; Scorza FB; Mahmood K
Vaccine; 2020 Dec; 38(52):8379-8386. PubMed ID: 33229107
[TBL] [Abstract][Full Text] [Related]
14. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
15. Cell culture influenza vaccine: an Australian perspective.
Chang L; Crichton R; Nandapalan P
Dev Biol Stand; 1999; 98():177-81; discussion 197. PubMed ID: 10494971
[TBL] [Abstract][Full Text] [Related]
16. Alterations in growth requirements of kidney epithelial cells in defined medium associated with malignant transformation.
Taub M; U B; Chuman L; Rindler MJ; Saier MH; Sato G
J Supramol Struct Cell Biochem; 1981; 15(1):63-72. PubMed ID: 6265706
[TBL] [Abstract][Full Text] [Related]
17. Systematically experimental investigation on carcinogenesis or tumorigenicity of VERO cell lines of different karyotypes in nude mice in vivo used for viral vaccine manufacture.
Zhang DL; Ji L; Li LJ; Huang GS
Yi Chuan Xue Bao; 2004 Jul; 31(7):647-60. PubMed ID: 15473315
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a low-tumorigenic MDCK cell line and study of differential molecular networks.
Ma GL; Qiao ZL; He D; Wang J; Kong YY; Xin XY; Wen FQ; Bao SJ; Ma ZR; Wang FS; Xie J; Hu YH
Biologicals; 2020 Nov; 68():112-121. PubMed ID: 32928630
[TBL] [Abstract][Full Text] [Related]
19. Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response.
Seitz C; Isken B; Heynisch B; Rettkowski M; Frensing T; Reichl U
Appl Microbiol Biotechnol; 2012 Jan; 93(2):601-11. PubMed ID: 21915610
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
